A new chemo immunotherapy combination based on CD nanosponges against pancreatic cancer
 Pancreatic cancer is resistant not only to chemotherapy but also to immunotherapy; therefore, identifying strategic alternatives is still necessary. Recently,
A forum for researchers, students and applicants in the field of cyclodextrin technology
 Pancreatic cancer is resistant not only to chemotherapy but also to immunotherapy; therefore, identifying strategic alternatives is still necessary. Recently,